My apologies if this document has been mentioned and posted by someone before.
I came across it this morning while doing some research.
I don't recall seeing it before.
The Next Generation of Rare Disease Drug Policy Ensuring Both Innovation and Affordability
7 April 2022
https://icer.org/wp-content/uploads/2022/04/ICER-White-Paper_The-Next-Generation-of-Rare-Disease-Drug-Policy_040722.pdf
Extracts from page 19 onwards:
Noting:
"While orphan products range widely in price, a small proportion carry an extremely high price,
usually linked to very small (e.g. < 10,000) eligible patients. Research shows that orphan drugs
costing over $500,000 per year represent 5% of all orphan drugs and treat 0.08% of patients taking
orphan medications (ref 85)."
Here is the document referred to as Reference 85:
https://rarediseases.org/wp-content/uploads/2021/03/orphan-drugs-in-the-united-states-NRD-2020.pdf
GLTAHs
- Forums
- ASX - By Stock
- Trof Pricing - name your price
My apologies if this document has been mentioned and posted by...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.78 |
Change
-1.360(6.14%) |
Mkt cap ! $2.656B |
Open | High | Low | Value | Volume |
$22.06 | $22.11 | $20.63 | $8.616M | 407.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 593 | $20.77 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.78 | 10 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1065 | 20.730 |
2 | 4549 | 20.670 |
3 | 2504 | 20.660 |
1 | 300 | 20.650 |
2 | 485 | 20.640 |
Price($) | Vol. | No. |
---|---|---|
20.940 | 996 | 1 |
20.950 | 1065 | 2 |
21.000 | 1028 | 2 |
21.060 | 996 | 1 |
21.120 | 996 | 1 |
Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |